Company Description
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally.
It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components.
It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services.
This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets.
Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals.
This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies.
Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
| Country | United States |
| Founded | 1981 |
| IPO Date | Aug 23, 1989 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 2,974 |
| CEO | Mikhael Nassif |
Contact Details
Address: 620 Lesher Place Lansing, Michigan 48912-1595 United States | |
| Phone | 517 372 9200 |
| Website | neogen.com |
Stock Details
| Ticker Symbol | NEOG |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | June - May |
| Reporting Currency | USD |
| CIK Code | 0000711377 |
| CUSIP Number | 640491106 |
| ISIN Number | US6404911066 |
| Employer ID | 38-2367843 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Mikhael Nassif | Chief Executive Officer, President and Director |
| Amy M. Rocklin Ph.D. | Chief Legal and Compliance Officer and Corporate Secretary |
| David H. Naemura | Executive Officer |
| John Moylan | Vice President, Corporate Controller and Chief Accounting Officer |
| Dr. Jason W. Lilly M.B.A., Ph.D. | Chief Scientific Officer |
| Sarah Demey | Administrative Manager |
| Bill Waelke | Head of Investor Relations |
| Kevin M. Burke | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 15, 2025 | 8-K | Current Report |
| Sep 12, 2025 | ARS | Filing |
| Sep 12, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Sep 12, 2025 | DEF 14A | Other definitive proxy statements |
| Aug 21, 2025 | 8-K | Current Report |
| Aug 14, 2025 | 8-K | Current Report |
| Aug 14, 2025 | SCHEDULE 13G | Filing |
| Aug 13, 2025 | SCHEDULE 13G | Filing |
| Jul 30, 2025 | 10-K | Annual Report |
| Jul 30, 2025 | SCHEDULE 13G/A | Filing |